New Delhi: US-based buyout fund Platinum Equity Advisors has made its first signing Private equity deal In India, it has acquired a significant majority stake in Mumbai-based pharmaceuticals company Inventia Healthcare at a valuation of Rs 2,500 crore ($300 million), multiple people aware of the development said.

The two investors currently hold around 40 per cent stake in Inventia. Janak Shah and the family holds the rest. Rothschild and Stifel Financial Corp (Torreya) advised the funds, while Barclays advised Platinum. ET first reported the discussions with Platinum Equity in January.

As per the plan, the promoter family will retain a minority stake and manage the business, sources said. Mails sent to Platinum, Inventia Healthcare Investecent Capital And Jacob Ballas There was no response. Founded in 1995, California-based Platinum Equity has more than $48 billion in assets under management and a portfolio of nearly 50 operating companies globally. According to the company’s website, Platinum Equity has completed more than 450 acquisitions and debt financings over the past 28 years. In healthcare, Platinum owns LifeScan – a US-based manufacturer of glucose management products and solutions; and NDC, a US-based healthcare supply chain company.